Hyperbaric oxygen therapy for chronic heart failure
Part of Heart & circulation clinical trials.
This study tests whether adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard heart failure treatment can improve symptoms and heart function. It may help people with chronic heart failure who are on stable medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have chronic heart failure with a reduced ejection fraction (LVEF 40% or less).
- You have had heart failure symptoms for at least 3 months, and your medication has been stable for the past month.
- You are already taking the standard four heart failure medications (ARNI/ACEI/ARB, beta-blocker, MRA, and SGLT2 inhibitor) for at least 2 weeks.
- You have no recent heart attack, unstable angina, or hospitalization for heart failure in the past 2-4 weeks.
- You are able to walk at least 450 meters in 6 minutes and do not have conditions that prevent hyperbaric oxygen therapy (like claustrophobia or untreated pneumothorax).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a breathing-focused treatment to help people with HFpEF (a type of heart failure) feel and function better. It may help improve daily activity by addressing breathing limits that commonly come with this condition.
This trial tests whether a structured exercise training program can improve symptoms and quality of life in people with heart failure with preserved ejection fraction (HFpEF), a condition where the heart pumps normally but is too stiff to fill properly. Participants will receive exercise training alongside their usual heart failure medications.
This study tests whether using a high-flow nasal cannula, a device that delivers moistened oxygen through the nose, while exercising on a treadmill helps people with heart failure walk or exercise longer. It may improve your exercise tolerance and quality of life during cardiac rehabilitation.
This study tests whether breathing muscle training can improve exercise capacity and symptoms in people with a type of heart failure called HFpEF. You may qualify if you are already on certain heart medications and are stable enough to exercise.
This study tests if adding inspiratory muscle training (exercises for breathing muscles) to standard cardiac rehab helps people with heart failure exercise better. It aims to improve how you feel and function.
This study tests whether breathing pure oxygen in a pressurized chamber can reduce fatigue and improve symptoms in people with mild-to-moderate chronic fatigue syndrome (ME/CFS). The therapy may help your body recover better by increasing oxygen supply to affected tissues.
Hear when a new Chronic Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.